Major Depressive Disorder patients display a reduced ability to feel pleasant experiences known as Anhedonia. Such a feature provides difficulties when treating depression and engaging patients during clinical trials.
Michele Garibbo
Advertisement
Articles by Michele Garibbo
Advertisement
Latest Updated Articles
Leverage Site-Owned Tech to Improve Trial RetentionPublished: April 25th 2016 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
2
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
3
Are Clinical Trial Diversity Initiatives at Risk of Being Dismantled?
4
Labels That Withstand Liquid Nitrogen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
